Hind Rafei, Assistant Professor at MD Anderson Cancer Center, shared a post on LinkedIn:
“So grateful to be a part of this new cohort of Convergent Science Virtual Cancer Center scholars, which includes generous funding from the United States Department of War for our efforts to improve CAR-T cell therapy for pancreatic cancer, but more importantly access to this prestigious network of colleagues, career guides, and CSVCC leadership.
Last week we attended our first lab meeting, so excited to continue these collaborative meetings for the next 4 years!
Thank you to Jeff Molldrem, Anirban Maitra, Eyal Gottlieb, Ken Chen, Abhinav Jain, Ph.D. for their collaboration and expertise UT MD Anderson.”
Other articles featuring Hind Rafei on OncoDaily.